Financhill
Sell
29

EGY Quote, Financials, Valuation and Earnings

Last price:
$4.30
Seasonality move :
11.62%
Day range:
$4.22 - $4.39
52-week range:
$4.03 - $7.51
Dividend yield:
5.8%
P/E ratio:
5.07x
P/S ratio:
0.82x
P/B ratio:
0.89x
Volume:
1.5M
Avg. volume:
1.1M
1-year change:
-6.71%
Market cap:
$447.1M
Revenue:
$455.1M
EPS (TTM):
$0.85
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $96.8M $77.4M $199.1M $354.3M $455.1M
Revenue Growth (YoY) -19.37% -20.01% 157.17% 77.99% 28.43%
 
Cost of Revenues $57M $56.9M $102.3M $160.8M $268.5M
Gross Profit $39.7M $20.5M $96.8M $193.5M $186.6M
Gross Profit Margin 41.08% 26.46% 48.61% 54.62% 41.01%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.9M $10.7M $14.8M $10.1M $23.8M
Other Inc / (Exp) -$543K -$25.1M -$20.2M -$57.8M -$4.6M
Operating Expenses $18.9M $16M $16.8M $10.3M $25.4M
Operating Income $20.9M $4.5M $80M $183.2M $161.2M
 
Net Interest Expenses -- -- -- $2M $6.5M
EBT. Incl. Unusual Items $21M -$20.4M $59.8M $123.4M $150.1M
Earnings of Discontinued Ops. $5.4M -$98K -$98K -$72K -$15K
Income Tax Expense $23.9M $27.7M -$22.2M $71.4M $89.8M
Net Income to Company $2.6M -$48.2M $81.8M $51.9M $60.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.6M -$48.2M $81.8M $51.9M $60.4M
 
Basic EPS (Cont. Ops) $0.04 -$0.83 $1.38 $0.74 $0.56
Diluted EPS (Cont. Ops) $0.04 -$0.83 $1.37 $0.73 $0.56
Weighted Average Basic Share $59.1M $57.6M $58.2M $69.6M $106.4M
Weighted Average Diluted Share $59.1M $57.6M $58.8M $70M $106.6M
 
EBITDA $28.2M $14.1M $101M $231.4M $276.5M
EBIT $20.9M $4.5M $80M $183.2M $161.2M
 
Revenue (Reported) $96.8M $77.4M $199.1M $354.3M $455.1M
Operating Income (Reported) $20.9M $4.5M $80M $183.2M $161.2M
Operating Income (Adjusted) $20.9M $4.5M $80M $183.2M $161.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $21M $64M $90M $116.3M $140.3M
Revenue Growth (YoY) 3.91% 205.12% 40.76% 29.16% 20.7%
 
Cost of Revenues $13.9M $40.2M $44.2M $72.5M $89.4M
Gross Profit $7.1M $23.7M $45.8M $43.8M $51M
Gross Profit Margin 33.68% 37.09% 50.9% 37.65% 36.33%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2M $2.9M $2M $6.2M $6.9M
Other Inc / (Exp) -$4K -$5.8M -$12.8M -$2.1M $69K
Operating Expenses $2.2M $3.4M $3.1M $8.2M $6.9M
Operating Income $4.8M $20.3M $42.8M $35.5M $44.1M
 
Net Interest Expenses -- -- $234K $1.4M $588K
EBT. Incl. Unusual Items $4.8M $14.6M $29.7M $32M $43.6M
Earnings of Discontinued Ops. $11K -$20K -$26K -- --
Income Tax Expense -$2.8M -$17.2M $22.8M $25.8M $32.6M
Net Income to Company $7.6M $31.7M $6.9M $6.1M $11M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7.6M $31.7M $6.9M $6.1M $11M
 
Basic EPS (Cont. Ops) $0.13 $0.53 $0.12 $0.06 $0.10
Diluted EPS (Cont. Ops) $0.13 $0.53 $0.11 $0.06 $0.10
Weighted Average Basic Share $57.5M $58.6M $59.1M $106.3M $103.7M
Weighted Average Diluted Share $57.7M $58.9M $59.5M $106.4M $103.8M
 
EBITDA $7.1M $27.3M $38.9M $65.9M $91.2M
EBIT $4.8M $20.3M $30M $33.4M $44.2M
 
Revenue (Reported) $21M $64M $90M $116.3M $140.3M
Operating Income (Reported) $4.8M $20.3M $42.8M $35.5M $44.1M
Operating Income (Adjusted) $4.8M $20.3M $30M $33.4M $44.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $88.1M $177.1M $331.5M $406.7M $545.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $62.5M $104.2M $133.9M $277.7M $339.1M
Gross Profit $25.6M $72.8M $197.5M $129M $206.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.9M $17M $13.1M $16.4M $28.2M
Other Inc / (Exp) -$27.3M -$17.9M -$59.9M -$11M $17M
Operating Expenses $9.4M $23M $15.1M $17.6M $27.6M
Operating Income $16.2M $49.8M $182.4M $111.4M $179.2M
 
Net Interest Expenses -- -- $354K $7.1M $3.7M
EBT. Incl. Unusual Items -$10.8M $31.9M $122.2M $93.3M $192.5M
Earnings of Discontinued Ops. -$78K -$129K -$84K -$14K --
Income Tax Expense $32.7M -$12.1M $53.6M $59.2M $101.7M
Net Income to Company -$43.6M $43.9M $68.5M $34.1M $90.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$43.6M $43.9M $68.5M $34.1M $90.8M
 
Basic EPS (Cont. Ops) -$0.75 $0.74 $1.15 $0.32 $0.85
Diluted EPS (Cont. Ops) -$0.75 $0.74 $1.14 $0.32 $0.85
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $26.7M $68M $150.9M $279.4M $327.2M
EBIT $16.2M $49.8M $124.9M $158.2M $200.9M
 
Revenue (Reported) $88.1M $177.1M $331.5M $406.7M $545.9M
Operating Income (Reported) $16.2M $49.8M $182.4M $111.4M $179.2M
Operating Income (Adjusted) $16.2M $49.8M $124.9M $158.2M $200.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $63.1M $162.7M $295.1M $347.5M $396.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $47.4M $94.7M $126.4M $243.3M $272.4M
Gross Profit $15.6M $68M $168.8M $104.2M $124.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6M $12.2M $10.5M $16.8M $21.2M
Other Inc / (Exp) -$25M -$17.8M -$57.5M -$10.1M $12.3M
Operating Expenses $6.9M $13.9M $12.3M $20.1M $23.1M
Operating Income $8.8M $54.1M $156.5M $84M $101.3M
 
Net Interest Expenses -- -- $355K $5.4M $2.6M
EBT. Incl. Unusual Items -$16.1M $36.3M $98.7M $68.6M $110.9M
Earnings of Discontinued Ops. -$41K -$72K -$58K -- --
Income Tax Expense $28.5M -$11.3M $64.5M $52.2M $64.1M
Net Income to Company -$44.6M $47.5M $34.1M $16.4M $46.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$44.6M $47.5M $34.1M $16.4M $46.8M
 
Basic EPS (Cont. Ops) -$0.77 $0.80 $0.57 $0.15 $0.44
Diluted EPS (Cont. Ops) -$0.77 $0.80 $0.56 $0.15 $0.44
Weighted Average Basic Share $172.9M $174.3M $176.7M $320.6M $310.9M
Weighted Average Diluted Share $173.3M $176M $178M $322.8M $312.1M
 
EBITDA $17.1M $71M $120.8M $168.9M $219.6M
EBIT $8.8M $54.1M $99M $73.9M $113.6M
 
Revenue (Reported) $63.1M $162.7M $295.1M $347.5M $396.8M
Operating Income (Reported) $8.8M $54.1M $156.5M $84M $101.3M
Operating Income (Adjusted) $8.8M $54.1M $99M $73.9M $113.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $45.9M $47.9M $48.7M $37.2M $121M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $14.3M -- $22.5M $52.1M $44.9M
Inventory $1.1M $3.9M $1.6M $3.3M $1.9M
Prepaid Expenses -- -- -- $18.8M $10.7M
Other Current Assets $3.3M $4.2M $5.2M -- --
Total Current Assets $69.8M $64M $88.3M $200.1M $228.1M
 
Property Plant And Equipment $101.6M $59.6M $104.6M $588.7M $552.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $12.3M $13.4M $24.7M $24.2M $9.5M
Total Assets $211.5M $141.2M $263.1M $855.6M $823.2M
 
Accounts Payable $15.9M $16.7M $18.8M $59.9M $22.2M
Accrued Expenses $22.8M $8.8M $23.5M $55.2M $39.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $12M $12.9M $9.6M $10.1M $12.5M
Other Current Liabilities $2.7M $4.3M $7.2M $8.2M $6.8M
Total Current Liabilities $63.8M $52.6M $84.3M $162.1M $127.5M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $101.8M $79.8M $118.8M $389.5M $344.4M
 
Common Stock $6.8M $6.8M $7M $11.9M $12.1M
Other Common Equity Adj -- -- -- $1.2M $2.9M
Common Equity $109.7M $61.5M $144.3M $466.1M $478.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $109.7M $61.5M $144.3M $466.1M $478.8M
 
Total Liabilities and Equity $211.5M $141.2M $263.1M $855.6M $823.2M
Cash and Short Terms $45.9M $47.9M $48.7M $37.2M $121M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $42M $52.8M $69.3M $103.4M $89.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $6.1M -- $16.8M $22.8M $84.3M
Inventory $781K $2.6M $4.3M $9.3M $4.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $4.3M $5.4M $12.6M $16.1M $15.1M
Total Current Assets $54.4M $64.1M $123.3M $218.1M $236.8M
 
Property Plant And Equipment $64.5M $87.1M $198M $559.4M $617M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $12.8M $25.2M $26.1M $9.7M $16.8M
Total Assets $135.4M $206.3M $394.8M $827.8M $937.9M
 
Accounts Payable $4.7M $8.4M $30.3M $43.9M $15M
Accrued Expenses $8.7M $14.2M $40.5M $43.8M $57.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $12.7M $12.7M $1.5M $11.3M $12.9M
Other Current Liabilities $1.8M $13.2M $14.2M $6.4M $7.4M
Total Current Liabilities $37.8M $63.3M $143M $166.8M $176.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $70.8M $96.7M $221.1M $383.5M $436.9M
 
Common Stock $6.8M $7M $7M $12.1M $12.2M
Other Common Equity Adj -- -- -- $844K $1M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $64.7M $109.6M $173.7M $444.4M $501M
 
Total Liabilities and Equity $135.4M $206.3M $394.8M $827.8M $937.9M
Cash and Short Terms $42M $52.8M $69.3M $103.4M $89.1M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.6M -$48.2M $81.8M $51.9M $60.4M
Depreciation & Amoritzation $7.3M $9.6M -- -- --
Stock-Based Compensation $3.5M $114K $2.5M $2.2M $3.3M
Change in Accounts Receivable -$2.5M $15.7M -$22.6M $3.9M $24M
Change in Inventories -$287K -$2.8M $5M -$1.7M $1.4M
Cash From Operations $26.5M $27.5M $50.1M $128.8M $223.6M
 
Capital Expenditures $10.3M $24.3M $39.1M $159.9M $97.2M
Cash Acquisitions -- -- -- $36.7M --
Cash From Investing -$10.3M -$24.3M -$39.1M -$123.2M -$97.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$9.4M -$26.8M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$3M -$7.2M
Repurchase of Common Stock -$3.9M -$992K -$1.4M -$3.8M -$23.6M
Other Financing Activities -- -- -- -$2.1M --
Cash From Financing -$3.7M -$929K -$57K -$18M -$56.8M
 
Beginning Cash (CF) $46.7M $59.1M $61.3M $72.3M $59.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $12.5M $2.2M $11M -$12.3M $69.6M
Ending Cash (CF) $59.1M $61.3M $72.3M $59.8M $129.2M
 
Levered Free Cash Flow $16.1M $3.1M $11.1M -$31.1M $126.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.6M $31.7M $6.9M $6.1M $11M
Depreciation & Amoritzation $2.3M -- -- -- --
Stock-Based Compensation -$248K $25K $36K $1.1M $1.5M
Change in Accounts Receivable $5.4M $28.2M $46.2M $33.4M -$25.5M
Change in Inventories $72K $551K $9.6M $1.5M $2.5M
Cash From Operations -$1.2M $33.6M $60.7M $94.2M $47.8M
 
Capital Expenditures $2.2M $4.2M $43.6M $22.5M $12.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.2M -$4.2M -$43.6M -$22.5M -$12.4M
 
Dividends Paid (Ex Special Dividend) -- -- -$1.9M -$6.7M -$6.6M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$125K -$1.9M -$2.1M
Repurchase of Common Stock -- -$258K -- -$6.1M -$1K
Other Financing Activities -- -- -$84K -$53K $1K
Cash From Financing -- -$6K -$2.2M -$14.5M -$8.7M
 
Beginning Cash (CF) $58.3M $47.6M $75.1M $54.3M $78.1M
Foreign Exchange Rate Adjustment -- -- -- -$36K $229K
Additions / Reductions -$3.4M $29.4M $15M $57.2M $26.7M
Ending Cash (CF) $54.9M $77M $90.1M $111.5M $105M
 
Levered Free Cash Flow -$3.4M $29.4M $17.1M $71.7M $35.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$43.6M $43.9M $68.5M $34.1M $90.8M
Depreciation & Amoritzation $10.5M -- -- -- --
Stock-Based Compensation -$1.4M $4.3M $2.7M $2.2M $4.4M
Change in Accounts Receivable $1.5M $17M -$35.1M $32.8M -$48M
Change in Inventories -$6K $934K -$1.7M -$5M $19.5M
Cash From Operations $16.5M $55.1M $133.1M $171M $121M
 
Capital Expenditures $29.3M $33M $112M $133.4M $81.4M
Cash Acquisitions -- -- -- -- $412K
Cash From Investing -$29.3M -$33M -$112M -$96.7M -$81M
 
Dividends Paid (Ex Special Dividend) -- -- -$5.8M -$23.7M -$26.3M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$193K -$8.1M -$8.2M
Repurchase of Common Stock -$2.5M -$1.4M -$788K -$20.5M -$12.9M
Other Financing Activities -- -- -- -- --
Cash From Financing -$2.4M -$60K -$8M -$52.3M -$46.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$15.2M $22.1M $13.1M $22M -$6.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$12.8M $22.1M $21.1M $37.5M $39.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$44.6M $47.5M $34.1M $16.4M $46.8M
Depreciation & Amoritzation $8.3M -- -- -- --
Stock-Based Compensation -$2.1M $2.1M $2.3M $2.3M $3.4M
Change in Accounts Receivable $8.7M $9.9M -$2.6M $26.3M -$45.6M
Change in Inventories $291K $4.1M -$2.7M -$6M $12.2M
Cash From Operations $19.1M $46.7M $129.7M $171.8M $69.2M
 
Capital Expenditures $22.3M $31M $103.9M $77.4M $61.5M
Cash Acquisitions -- -- -- -- $412K
Cash From Investing -$22.3M -$31M -$103.9M -$77.4M -$61.1M
 
Dividends Paid (Ex Special Dividend) -- -- -$5.8M -$20.2M -$19.6M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$193K -$5.2M -$6.3M
Repurchase of Common Stock -$990K -$1.4M -$788K -$17.5M -$6.8M
Other Financing Activities -- -- -$1.5M -$83K --
Cash From Financing -$990K -$121K -$8.1M -$42.4M -$32.3M
 
Beginning Cash (CF) $191.5M $152.8M $193.7M $174.4M $327M
Foreign Exchange Rate Adjustment -- -- -- -$321K -$4K
Additions / Reductions -$4.2M $15.6M $17.8M $52.1M -$24.2M
Ending Cash (CF) $187.3M $168.5M $211.5M $226.1M $302.8M
 
Levered Free Cash Flow -$3.3M $15.8M $25.8M $94.4M $7.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock